10:14:33 EDT Fri 29 Mar 2024
Enter Symbol
or Name
USA
CA



Aphria Inc
Symbol APHA
Shares Issued 250,581,402
Close 2019-04-18 C$ 10.25
Market Cap C$ 2,568,459,371
Recent Sedar Documents

Aphria receives cannabis cultivation licence in Germany

2019-04-18 16:44 ET - News Release

Mr. Hendrik Knopp reports

APHRIA SECURES CANNABIS CULTIVATION LICENSE IN GERMANY

Aphria Inc.'s German subsidiary, Aphria Deutschland GmbH, has secured the previously announced licence for the domestic cultivation of medical cannabis from the German Federal Institute for Drugs and Medical Devices (BfArM), following the conclusion of a mandatory 10-day standstill period for public contracts. Aphria was granted a cultivation licence for four of the nine total lots awarded by BfArM and is awaiting the completion of the tender process for the four remaining lots under review, one of which was provisionally awarded to Aphria Germany.

"Aphria thanks the BfArM for their diligent examination and validation of our approach for domestic cultivation with this licence," said Hendrik Knopp, managing director of Aphria Germany. "Construction on our 8,000-square-metre indoor cultivation facility is already under way and we anticipate it will be fully operational by summer 2020. We are pleased to additionally support German patients in the upcoming months with high-quality imported cannabis flower and oils from Denmark and Canada."

Aphria Germany is building its indoor growing facility in Neumunster and is completing work on a state-of-the-art Good Manufacturing Practices-certified cannabis vault in Bad Bramstedt for the import of cannabis flowers and oil from Canada and Denmark. Aphria Germany also holds a 25.1-per-cent interest in Berlin-based Schoneberg Hospital, which provides access to both doctors and patients for education on the benefits of medical cannabinoids. Earlier this month, the company launched CannRelief, a CBD-based nutraceutical and cosmetics product line for the German market, produced in the European Union and distributed by CC Pharma, a subsidiary of Aphria, with access to more than 13,000 pharmacies throughout Germany.

About Aphria Inc.

Aphria is a leading global cannabis company driven by an unrelenting commitment to its people, product quality and innovation. Headquartered in Leamington, Ont. -- the greenhouse capital of Canada -- Aphria has been setting the standard for the low-cost production of safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most natural conditions possible.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.